Archives: Speakers

Raf Derhaeg

I started in 2006 as a traffic and safety regulator at Infrabel at the signal box of Brussels-North, one of the two main signal boxes of the Brussels area.

In 2010 I was promoted after internal exams and became head of the signal box.

One year later, in 2011, I was again promoted and became Safety Analyst.

In 2013 I moved back to the Brussels-North signal box as head of supervision.

From September 2014 until april I worked at the planning of infrastructure works for the Brussels area.

As of april 2018 I was transferred to the division of Emergency Planning and Tunnel Safety as Tunnel Safety Supervisor for the Brussels tunnels.

Marius Raddum

Marius Raddum is the Accident investigator for AIBN (Accident Investigation Board Norway), Road traffic, since 2011. Marius have a Civil Engineer education and has investigated 6 major tunnel fires in Norway: Oslofjordtunnelen (2011); Gudvangatunnelen I (2013); Gudvangatunnelen II (2015); Skatestraumtunnelen (2015); Fjaerlandstunnelen (2017) and Oslofjordtunnelen (2017).

Anastasia Gutierrez

Anastasia Gutierrez is a Director, Clinical Program Management at Bellicum Pharmaceuticals, where she is managing the execution of Adaptive Cell Therapy programs including timelines, deliverables, scope, risks and budget. Anastasia has almost 20 years of clinical research experience, with a focus on early phase oncology studies. Prior to joining Bellicum, Anastasia spent a number of years on the CRO side of industry where she managed a number of global Phase I-IV studies across Americas, Europe, Middle East, Africa and Asia/Pacific Rim.  She is a native of Russia and has her medical degree from Smolensk State Medical Academy. She came to the US in 2003 and settled in the Houston area, where she currently lives with her family

Jay Venkatachalam

Jay joined Biogen in 2011 as an MBA Intern in the Supply Chain Group. Jay has 10 years of supply chain experience and 8 years of that has been in the Clinical Supply Industry. Prior to joining Biogen, Jay worked for a third party logistics provider that serviced clients like KFC and McDonalds where he gained his core supply chain skills as a management trainee. Through his stint at Biogen, Jay has worked in Clinical Logistics and Clinical Planning managing end to end Clinical Supply Chain Activities for a number of trials in all phases and has also been involved in a number of pre-approval regulatory inspections. Jay has also led multiple process improvement initiatives at Biogen to streamline overall clinical supply end to end processes and system integrations.

Jane M. Jacob

With over 15 years’ experience in clinical research, following 15 years in academia, Dr. Jacob ‘s experience working within the corporate infrastructure as well as establishing successful sponsor/site relationships, has allowed her to successfully develop and launch both large and small clinical trials across the research spectrum – retrospective, post market and IDE  studies.  She has been a study coordinator, then a CRA, a manager, director and is now Vice President of Research and Clinical Affairs at several medical device companies.

Jane Hart

Jane Hart has worked in the Clinical Research Industry for over 22 years, with 5 of those years in the Medical Device Industry.  She joined KCI in 2017 leading the Clinical Operations, Data Management, Biostatistics and Global Safety departments. Her team is focused on generating evidence to support the safe and effective use of KCI products primarily through company sponsored and investigator sponsored research. Jane started her career in Australia working in breast cancer research and relocated to the US 17 years ago.  She is experienced with executing pre and post market studies globally for both drug and devices.  Highlights of studies she has managed include FDA approval of a nanocoated cardiac stent, hormonal therapy for breast cancer and chemotherapy for hematological malignancies.

 

Jane is currently a member of the Association of Clinical Research Professionals (ACRP) and is PMP certified with the Project Management Institute.  In addition, Jane is a graduate of Charles Sturt University, Australia.

Patrick Moran

Patrick T. Moran is the founding board member of the Texas Cannabis Industry Association. Beginning October of 2013, he started to apply his professional experience to the emerging cannabis industry. He maintains Texas State Bar licensure and invested time & energy into the last three Texas legislative sessions, to help advance cannabis law reform. Mr. Moran is also founder and CEO of Pebble Global Holdings (www.pebble.life) an emerging bio-pharmaceutical company committed to natural plant solutions that include CBD-based products. Coming from a family with three generations of medical professionals on his mother’s side and six generations of industrial-scale agriculture & entrepreneurship on his father’s, he has led the company’s R&D, guided overall strategy and successful fundraising. Post Texas Hemp legalization, he is now helping advise TCIA coming into the 2020 elections and using the results of Pebble’s in-house clinical trial to inform subsequent larger scale studies.

Jakob Böttger

After several years in the rescue service, Jakob Böttger specialized in the field of rescue engineering. As head of planning and deployment of the fire brigade, he is primarily active in risk assessment and in the derivation of measures in emergency plans for railway incidents. These include projects at the Lötschberg base tunnel, the Gotthard and Ceneri base tunnel and a number of smaller tunnels operated by BLS Netz AG.